Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome
Open Access
- 11 April 2013
- Vol. 5 (4), 605-617
- https://doi.org/10.3390/toxins5040605
Abstract
Over the past 20 years, exposure to mycotoxin producing mold has been recognized as a significant health risk. Scientific literature has demonstrated mycotoxins as possible causes of human disease in water-damaged buildings (WDB). This study was conducted to determine if selected mycotoxins could be identified in human urine from patients suffering from chronic fatigue syndrome (CFS). Patients (n = 112) with a prior diagnosis of CFS were evaluated for mold exposure and the presence of mycotoxins in their urine. Urine was tested for aflatoxins (AT), ochratoxin A (OTA) and macrocyclic trichothecenes (MT) using Enzyme Linked Immunosorbent Assays (ELISA). Urine specimens from 104 of 112 patients (93%) were positive for at least one mycotoxin (one in the equivocal range). Almost 30% of the cases had more than one mycotoxin present. OTA was the most prevalent mycotoxin detected (83%) with MT as the next most common (44%). Exposure histories indicated current and/or past exposure to WDB in over 90% of cases. Environmental testing was performed in the WDB from a subset of these patients. This testing revealed the presence of potentially mycotoxin producing mold species and mycotoxins in the environment of the WDB. Prior testing in a healthy control population with no history of exposure to a WDB or moldy environment (n = 55) by the same laboratory, utilizing the same methods, revealed no positive cases at the limits of detection.Keywords
This publication has 57 references indexed in Scilit:
- Toxicopathological studies on the effects of aflatoxin B1, ochratoxin A and their interaction in New Zealand White rabbitsExperimental and Toxicologic Pathology, 2013
- A Water-Damaged Home and Health of Occupants: A Case StudyJournal of Environmental and Public Health, 2011
- Trichothecene Mycotoxins Inhibit Mitochondrial Translation—Implication for the Mechanism of ToxicityToxins, 2011
- Co-occurrence of toxic bacterial and fungal secondary metabolites in moisture-damaged indoor environmentsIndoor Air, 2011
- Correlation between ERMI Values and Other Moisture and Mold Assessments of Homes in the American Healthy Homes SurveyJournal of Urban Health, 2009
- Mycotoxin Detection in Human Samples from Patients Exposed to Environmental MoldsInternational Journal of Molecular Sciences, 2009
- Fungal fragments in moldy houses: A field study in homes in New Orleans and Southern OhioAtmospheric Environment, 2007
- Mycotoxins in indoor environmentsMycotoxin Research, 2005
- Allergy and “toxic mold syndrome”Annals of Allergy, Asthma & Immunology, 2005
- Ultrastructural changes in murine lymphocytes induced by aflatoxin B1Mycopathologia, 1994